Role of calcium-sensing receptor in bone biology

Indian Journal of Medical Research

Volumn 127, Issue 3, 2008, Pages 274-286

  Sharan, Kunal ^a   Siddiqui, J A ^a   Swarnkar, Gaurav ^a   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Bone microenvironment; Calcium sensing receptor; CaR gene mutation; Hypercalcaemia; Osteoblasts

Indexed keywords

AMINO ACID DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CALCIMIMETIC AGENT; CALCIUM; CALCIUM ION; CALCIUM SENSING RECEPTOR; CINACALCET; GROWTH FACTOR; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PEPTIDE DERIVATIVE; SPERMINE; STRONTIUM RANELATE;

APOPTOSIS; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL HOMING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; HEMATOPOIETIC STEM CELL; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; KIDNEY TUBULE ABSORPTION; LIVER CELL; MALIGNANT NEOPLASTIC DISEASE; MICROENVIRONMENT; MUTATIONAL ANALYSIS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW;

BONE AND BONES; BONE DISEASES; CALCIUM; HUMANS; HYPERCALCEMIA; RECEPTORS, CALCIUM-SENSING;

EID: 46649097830     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. 2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411.
2. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-80.
3. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-97.
4. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, Hebert SC. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 1995; 92: 131-5.
5. Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983; 56: 572-81.
6. Nemeth EF, Scarpa A. Cytosolic Ca2+ and the regulation of secretion in parathyroid cells. FEBS Lett 1986; 203: 15-9.
7. Nemeth EF, Scarpa A. Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. J Biol Chem 1987; 262: 5188-96.
8. Nemeth EF, Kosz LM. Adenine nucleotides mobilize cellular Ca2+ and inhibit parathyroid hormone secretion. Am J Physiol 1989; 257: E505-13.
9. Cima RR, Cheng I, Klingensmith ME, Chattopadhyay N, Kifor O, Hebert SC, et al. Identification and functional assay of an extracellular calcium-sensing receptor in Necturus gastric mucosa. Am J Physiol 1997; 273: G1051-60.
10. Ruat M, Molliver ME, Snowman AM, Snyder SH. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 1995; 92: 3161-5.
11. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270: 12919-25.
12. Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR- transfected HEK293 cells. J Biol Chem 1998; 273: 23605-10.
13. Ward DT, Brown EM, Harris HW. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem 1998; 273: 14476-83.
14. Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 2003; 4: 530-8.
15. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 1999; 106: 238-53.
16. +)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-303.
17. Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 1994; 8: 303-7.
18. Brown EM. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinol Metab Clin North Am 2000; 29: 503-22.
19. Foley TP Jr, Harrison HC, Arnaud CD, Harrison HE. Familial benign hypercalcemia. J Pediatr 1972; 81: 1060-7.
20. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981; 60: 397-412.
21. Law WM Jr, Heath H 3rd. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med 1985; 102: 511-9.
22. Heath H 3rd, Jackson CE, Otterud B, Leppert MF. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 1993; 53: 193-200.
23. Davies M, Klimiuk PS, Adams PH, Limb GA, Large DM, Anderson DC. Familial hypocalciuric hypercalcaemia and acute pancreatitis. Br Med J (Clin Res Ed) 1981; 282: 1023-5.
24. Bai M, Janicic N, Trivedi S, Quinn SJ, Cole DE, Brown EM, et al. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 1997; 99: 1917-25.
25. Heath H, 3rd. Familial benign hypercalcemia-from clinical description to molecular genetics. West J Med 1994; 160: 554-61.
26. Pearce S, Steinmann B. Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol (Oxf) 1999; 50: 691-3.
27. Marx SJ, Lasker RD, Brown EM, Fitzpatrick LA, Sweezey NB, Goldbloom RB, et al. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. J Clin Endocrinol Metab 1986; 62: 445-9.
28. Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994; 93: 1108-12.
29. Kobayashi M, Tanaka H, Tsuzuki K, Tsuyuki M, Igaki H, Ichinose Y, et al. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 2716-9.
30. +-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997; 99: 88-96.
31. +)-sensing receptor. J Clin Endocrinol Metab 1997; 82: 2710-5.
32. +)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996; 5: 601-6.
33. Lovlie R, Eiken HG, Sorheim JI, Boman H. The Ca(2+)-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Hum Genet 1996; 98: 129-33.
34. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995; 11: 389-94.
35. Ray K, Northup J. Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor. J Biol Chem 2002; 277: 18908-13.
36. Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 2004; 308: 627-35.
37. Nemeth EF, Delmar EG, Heaton WL, Miller MA, Lambert LD, Conklin RL, et al. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 2001; 299: 323-31.
38. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-41.
39. Dvorak MM, Riccardi D. Ca2+ as an extracellular signal in bone. Cell Calcium 2004; 35: 249-55.
40. Sugimoto T, Kanatani M, Kano J, Kaji H, Tsukamoto T, Yamaguchi T, et al. Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast-like cells. J Bone Miner Res 1993; 8: 1445-52.
41. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996; 137: 4058-60.
42. Quarles LD, Hartle JE, 2nd, Siddhanti SR, Guo R, Hinson TK. A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor. J Bone Miner Res 1997; 12: 393-402.
43. Yamaguchi T, Chattopadhyay N, Kifor O, Butters RR, Jr, Sugimoto T, Brown EM. Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 1998; 13: 1530-8.
44. Godwin SL, Soltoff SP. Extracellular calcium and platelet-derived growth factor promote receptor-mediated chemotaxis in osteoblasts through different signaling pathways. J Biol Chem 1997; 272: 11307-12.
45. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96: 191-8.
46. Fukumoto S. Localization and function of calcium-sensing mechanism in bone cells. Nippon Rinsho 1998; 56: 1419-24.
47. Chang W, Tu C, Chen TH, Komuves L, Oda Y, Pratt SA, et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999; 140: 5883-93.
48. Takeyama S, Yoshimura Y, Shirai Y, Deyama Y, Hasegawa T, Yawaka Y, et al. Low calcium environment effects osteoprotegerin ligand/osteoclast differentiation factor. Biochem Biophys Res Commun 2000; 276: 524-9.
49. Kanatani M, Sugimoto T, Kanzawa M, Yano S, Chihara K. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Biochem Biophys Res Commun 1999; 261: 144-8.
50. +o)-sensing receptor in a mouse monocyte-macrophage cell line (J774): potential mediator of the actions of Ca2+o on the function of J774 cells. J Bone Miner Res 1998; 13: 1390-7.
51. Yamaguchi T, Ye C, Chattopadhyay N, Sanders JL, Vassilev PM, Brown EM. Enhanced expression of extracellular calcium sensing receptor in monocyte-differentiated versus undifferentiated HL-60 cells: potential role in regulation of a nonselective cation channel. Calcif Tissue Int 2000; 66: 375-82.
52. Kameda T, Mano H, Yamada Y, Takai H, Amizuka N, Kobori M, et al. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun 1998; 245: 419-22.
53. Mailland M, Waelchli R, Ruat M, Boddeke HG, Seuwen K. Stimulation of cell proliferation by calcium and a calcimimetic compound. Endocrinology 1997; 138: 3601-5.
54. Yamaguchi T, Kifor O, Chattopadhyay N, Brown EM. Expression of extracellular calcium (Ca2 + o)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem Biophys Res Commun 1998; 243: 753-7.
55. Yamaguchi T, Chattopadhyay N, Kifor O, Ye C, Vassilev PM, Sanders JL, et al. Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 2001; 280: C382-93.
56. Pi M, Quarles LD. Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors. J Cell Biochem 2005; 95: 1081-92.
57. Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 2005; 280: 40201-9.
58. Chattopadhyay N, Yano S, Tfelt-Hansen J, Rooney P, Kanuparthi D, Bandyopadhyay S, et al. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 2004; 145: 3451-62.
59. Ward BK, Magno AL, Davis EA, Hanyaloglu AC, Stuckey BG, Burrows M, et al. Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 2004; 89: 3721-30.
60. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, Brown EM. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 2007; 74: 438-47.
61. Hartle JE, 2nd, Prpic V, Siddhanti SR, Spurney RF, Quarles LD. Differential regulation of receptor-stimulated cyclic adenosine monophosphate production by polyvalent cations in MC3T3-E1 osteoblasts. J Bone Miner Res 1996; 11: 789-99.
62. Yamaguchi T, Chattopadhyay N, Kifor O, Sanders JL, Brown EM. Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Biochem Biophys Res Commun 2000; 279: 363-8.
63. Ye CP, Yamaguchi T, Chattopadhyay N, Sanders JL, Vassilev PM, Brown EM. Extracellular calcium-sensing-receptor (CaR)-mediated opening of an outward K(+) channel in murine MC3T3-E1 osteoblastic cells: evidence for expression of a functional CaR. Bone 2000; 27: 21-7.
64. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-19.
65. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997; 234: 137-42.
66. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-602.
67. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-76.
68. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402: 304-9.
69. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96: 3540-5.
70. Datta HK, MacIntyre I, Zaidi M. Intracellular calcium in the control of osteoclast function. I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazem. Biochem Biophys Res Commun 1990; 167: 183-8.
71. Zaidi M, MacIntyre I, Datta H. Intracellular calcium in the control of osteoclast function. II. Paradoxical elevation of cytosolic free calcium by verapamil. Biochem Biophys Res Commun 1990; 167: 807-12.
72. Miyauchi A, Hruska KA, Greenfield EM, Duncan R, Alvarez J, Barattolo R, et al. Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption. J Cell Biol 1990; 111: 2543-52.
73. +. Biochem Biophys Res Commun 1992; 187: 907-12.
74. Zaidi M, Kerby J, Huang CL, Alam T, Rathod H, Chambers TJ, et al. Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor". J Cell Physiol 1991; 149: 422-7.
75. + receptor is highly sensitive to activation by transition metal cations. Biochem Biophys Res Commun 1992; 187: 913-8.
76. Zaidi M, Datta HK, Patchell A, Moonga B, MacIntyre I. 'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem Biophys Res Commun 1989; 163: 1461-5.
77. Datta HK, MacIntyre I, Zaidi M. The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts. Biosci Rep 1989; 9: 747-51.
78. Moonga BS, Moss DW, Patchell A, Zaidi M. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J Physiol 1990; 429: 29-45.
79. Boonekamp PM, van der Wee-Pals LJ, van Wijk-van Lennep MM, Thesing CW, Bijvoet OL. Two modes of action of bisphosphonates on osteoctastic resorption of mineralized matrix. Bone Miner 1986; 1: 27-39.
80. + sensing. J Clin Invest 1995; 96: 1582-90.
81. Zaidi M, Adebanjo OA, Moonga BS, Sun L, Huang CL. Emerging insights into the role of calcium ions in osteoclast regulation. J Bone Miner Res 1999; 14: 669-74.
82. Mentaverri R, Yano S, Chattopadhyay N, Petit L, Kifor O, Kamel S, et al. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 2006; 20: 2562-4.
83. Lord BI, Testa NG, Hendry JH. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 1975; 46: 65-72.
84. Gong JK. Endosteal marrow: a rich source of hematopoietic stem cells. Science 1978; 199: 1443-5.
85. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001; 97: 2293-9.
86. Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005; 105: 2631-9.
87. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-41.
88. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-61.
89. Kuznetsov SA, Riminucci M, Ziran N, Tsutsui TW, Corsi A, Calvi L, et al. The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J Cell Biol 2004; 167: 1113-22.
90. Zhou H, Choong PF, Henderson S, Chou ST, Aspenberg P, Martin TJ, et al. Marrow development and its relationship to bone formation in vivo: a histological study using an implantable titanium device in rabbits. Bone 1995; 17: 407-15.
91. Deguchi K, Yagi H, Inada. M, Yoshizaki K, Kishimoto T, Komori T. Excessive extramedullary hematopoiesis in Cbfa1- deficient mice with a congenital lack of bone marrow. Biochem Biophys Res Commun 1999; 255: 352-9.
92. Jacenko O, Roberts DW, Campbell MR, McManus PM, Gress CJ, Tao Z. Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X. Am J Pathol 2002; 160: 2019-34.
93. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988; 175: 266-76.
94. House MG, Kohlmeier L, Chattopadhyay N, Kifor O, Yamaguchi T, Leboff MS, et al i. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997; 12: 1959-70.
95. Olszak IT, Poznansky MC, Evans RH, Olson D, Kos C, Pollak MR, et al. Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest 2000; 105: 1299-305.
96. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8: 98-101.
97. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, et al. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991; 73: 1309-15.
98. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 1980; 303: 1377-83.
99. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987; 237: 893-6.
100. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, et al. Evidence for a causal role of parathyroid hormone- related protein in the pathogenesis of human breast cancer- mediated osteolysis. J Clin Invest 1996; 98: 1544-9.
101. Iguchi H, Tanaka S, Ozawa Y, Kashiwakuma T, Kimura T, Hiraga T, et al. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone- related protein in bone metastasis. Cancer Res 1996; 56: 4040-3.
102. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al. Localization of parathyroid hormone- related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 1991; 51: 3059-61.
103. Brandt DW, Pandol SJ, Deftos LJ. Calcium-stimulated parathyroid hormone-like protein secretion: potentiation through a protein kinase-C pathway. Endocrinology 1991; 128: 2999-3004.
104. Kremer R, Woodworth CD, Goltzman D. Expression and action of parathyroid hormone-related peptide in human cervical epithelial cells. Am J Physiol 1996; 271: C164-71.
105. Merryman JI, Capen CC, McCauley LK, Werkmeister JR, Suter MM, Rosol TJ. Regulation of parathyroid hormone- related protein production by a squamous carcinoma cell line in vitro. Lab Invest 1993; 69: 347-54.
106. Rizzoli R, Feyen JH, Grau G, Wohlwend A, Sappino AP, Bonjour JP. Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol 1994; 143: 333-41.
107. Schramek H. MAP kinases: from intracellular signals to physiology and disease. News Physiol Sci 2002; 17: 62-7.
108. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 2000; 141: 4357-64.
109. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM. Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 2001; 281: E1267-74.
110. Tfelt-Hansen J, Chattopadhyay N, Yano S, Kanuparthi D, Rooney P, Schwarz P, et al. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy. Endocrinology 2004; 145: 1211-7.
111. Awata H, Huang C, Handlogten ME, Miller RT. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 2001; 276: 34871-9.
112. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 2001; 276: 34880-7.
113. Keller ET, Brown J. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem 2004; 91: 718-29.
114. MacLeod RJ, Chattopadhyay N, Brown EM. PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 2003; 284: E435-42.
115. MacLeod RJ, Yano S, Chattopadhyay N, Brown EM. Extracellular calcium-sensing receptor transactivates the epidermal growth factor receptor by a triple-membrane-spanning signaling mechanism. Biochem Biophys Res Commun 2004; 320: 455-60.
116. Tfelt-Hansen J, Yano S, John Macleod R, Smajilovic S, Chattopadhyay N, Brown EM. High calcium activates the EGF receptor potentially through the calcium-sensing receptor in Leydig cancer cells. Growth Factors 2005; 23: 117-23.
117. Tomlins SA, Bolllinger N, Creim J, Rodland KD. Cross-talk between the calcium-sensing receptor and the epidermal growth factor receptor in Rat-1 fibroblasts. Exp Cell Res 2005; 308: 439-45.
118. Yano S, Macleod RJ, Chattopadhyay N, Tfelt-Han sen J, Kifor O, Butters RR, et al. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. Bone 2004; 35: 664-72.
119. Tfelt-Hansen J, MacLeod RJ, Chattopadhyay N, Yano S, Quinn S, Ren X, et al. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab 2003; 285: E329-37.
120. Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997; 11: 433-41.
121. Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 2001; 86: 867-74.
122. Horwitz MJ, Stewart AF. Humoral hypercalcemia of malignancy. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. Favus MJ, editor. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2003. p. 246-50.